Algorae Pharmaceuticals Ltd

1AI

Company Profile

  • Business description

    Algorae Pharmaceuticals Ltd is an AI-enabled pharmaceutical company operating a synergistic dual-track business comprising AI-driven drug discovery and pharmaceutical commercialization. Its discovery activities are built around AlgoraeOS, its proprietary artificial intelligence (AI) drug-combination prediction platform, developed in collaboration with the UNSW AI Institute with support from CSIRO Data61, together with a therapeutic pipeline comprising AI-116 for dementia and AI-168 for cardiovascular disease. Its commercial activities are conducted through its wholly owned subsidiary, which sources, licenses, registers and supplies generic and specialty medicines in Australia and New Zealand through partnered manufacturers and established distribution channels.

  • Contact

    525 Collins Street
    Level 23, Rialto South Tower
    MelbourneVIC3000
    AUS

    T: +61 422180317

    https://www.algoraepharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    Employees

    48

Stocks News & Analysis

stocks

Reassuring organic growth for undervalued ASX share

Efficiency gains are starting to make their mark.
stocks

Big IPOs are enticing but are they good investments?

Historically, buzzy debuts have been painful for buyers.
stocks

This defensive ASX listed REIT offers a 5% yield

Solid outlook underpinned by rent uplifts and development pipeline.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,692.80143.80-1.63%
CAC 407,927.75152.99-1.89%
DAX 4024,802.78661.03-2.60%
Dow JONES (US)48,147.33949.73-1.93%
FTSE 10010,346.34106.34-1.02%
HKSE22,410.80430.82-1.89%
NASDAQ22,617.731,261.47-5.28%
Nikkei 22556,436.653,007.56-5.06%
NZX 50 Index14,107.41139.84-0.98%
S&P 5006,910.39265.44-3.70%
S&P/ASX 2008,592.60137.80-1.58%
SSE Composite Index3,533.7943.82-1.22%

Market Movers